Align Technology Inc

ALGNNASDAQ · USD
163.96USD0.00 (+0.31%)
879

Align Technology Inc (ALGN) Covered Calls

Align Technology Inc trades in the Medical Instruments & Supplies industry with an IV Rank of 21.83%, low versus the past year. ALGN's highest covered call setup is the $172.50 strike expiring Nov 20, 2026, sorted by theoretical annualized return. It's 5.53% out of the money with 3 days to expiration, a 5.56% return until expiration, and a 676.59% theoretical annualized return. Across the setups shown, annualized returns run from 177.27% to 676.59% at strikes between $170.00 and $230.00, with 3 to 59 days to expiration, as of Nov 17, 2026.

Read more

Running ALGN covered calls helps you generate income from Align Technology Inc shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best ALGN covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call pairs limited risk with a clear income profile. If ALGN stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling ALGN covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given ALGN covered call is worth writing.

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth.

2026-11-203172.505.530.052.55909.005.56676.59-0.03+0.22782.50
2026-11-203170.004.000.154.10669.004.09497.95-0.09+0.30583.95
2026-12-0417187.5014.710.055.302409.0014.74316.42-0.03+0.2105.25
2026-12-1124195.0019.300.055.103159.0019.33293.91-0.03+0.1815.05
2026-12-0417185.0013.180.055.102159.0013.21283.59-0.03+0.2135.05
2026-12-1831200.0022.350.051.303659.0022.38263.56-0.03+0.071511.25
2027-01-1559230.0040.710.055.106659.0040.74252.02-0.03+0.13555.05
2027-01-1559220.0034.590.202.105674.0034.71214.74-0.12+0.081,9081.90
2026-12-1831190.0016.240.601.702714.0016.60195.49-0.37+0.122721.10
2027-01-1559210.0028.470.304.904684.0028.66177.27-0.18+0.151024.60

As of Nov 17, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryMedical Instruments & Supplies
  • SectorHealthcare
  • IV Rank21.83% Low
  • Market cap (M$)11,557
  • 52 weeks high-18.20%
  • 52 weeks low24.26%
  • Analyst recommendationBuy
    2.29
  • Target price$185.08
    12.88% above the current stock price
  • Dividend—
  • Payout ratio0.00%
  • Earnings date2027-02-03
  • P/E23.82
  • Future P/E13.36
  • EPS (ttm)6.88
  • EPS growth next 5 years8.46%

As of Nov 18, 2026